The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients

Nephrol Dial Transplant. 2016 Oct;31(10):1746-53. doi: 10.1093/ndt/gfw099. Epub 2016 Jul 6.

Abstract

Background: We sought to determine whether the mode of sensitization in highly sensitized patients contributed to kidney allograft survival.

Methods: An analysis of the United Network for Organ Sharing dataset involving all kidney transplants between 1997 and 2014 was undertaken. Highly sensitized adult kidney transplant recipients [panel reactive antibody (PRA) ≥98%] were compared with adult, primary non-sensitized and re-transplant recipients. Kaplan-Meier survival analyses were used to determine allograft survival rates. Cox proportional hazards regression analyses were conducted to determine the association of graft loss with key predictors.

Results: Fifty-three percent of highly sensitized patients transplanted were re-transplants. Pregnancy and transfusion were the only sensitizing event in 20 and 5%, respectively. The 10-year actuarial graft survival for highly sensitized recipients was 43.9% compared with 52.4% for non-sensitized patients, P < 0.001. The combination of being highly sensitized by either pregnancy or blood transfusion increased the risk of graft loss by 23% [hazard ratio (HR) 1.230, confidence interval (CI) 1.150-1.315, P < 0.001], and the combination of being highly sensitized from a prior transplant increased the risk of graft loss by 58.1% (HR 1.581, CI 1.473-1.698, P < 0.001).

Conclusions: The mode of sensitization predicts graft survival in highly sensitized kidney transplant recipients (PRA ≥98%). Patients who are highly sensitized from re-transplants have inferior graft survival compared with patients who are highly sensitized from other modes of sensitization.

Keywords: graft survival; kidney transplantation.

MeSH terms

  • ABO Blood-Group System / immunology*
  • Allografts
  • Blood Transfusion
  • Female
  • Graft Rejection / immunology*
  • Graft Survival / immunology*
  • HLA Antigens / immunology*
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation / mortality*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Registries
  • Retrospective Studies
  • Survival Rate

Substances

  • ABO Blood-Group System
  • HLA Antigens